TELETRADER News
9/23, 1:38 AM (Source: TeleTrader)
more TeleTrader news

FDA approves booster Pfizer shot for over-65s and high-risk population

The United States Food and Drug Administration (FDA) amended its emergency use authorization (EUA) for the Pfizer/BioNTech COVID-19 vaccine to allow a single booster dose for certain individuals. Those over the age of 65, as well as younger individuals at high risk of severe COVID-19 and those with "frequent institutional or occupational exposure" to the virus can get a booster shot six months after their second dose.

"After considering the totality of the available scientific evidence and the deliberations of our advisory committee of independent, external experts, the FDA amended the EUA for the Pfizer-BioNTech COVID-19 Vaccine to allow for a booster dose in certain populations such as health care workers, teachers and daycare staff, grocery workers and those in homeless shelters or prisons, among others," said Acting FDA Commissioner Janet Woodcock.

Breaking the News / DJ